TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
SMP00320	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	0.00143859247257451	-6.54409009301064	38	13	0.0909090909090909	143	992	673,5567,5170,2002,8874,5290,5906,10411,998,2782,5594,5609,6195	BRAF,PRKACB,PDPK1,ELK1,ARHGEF7,PIK3CA,RAP1A,RAPGEF3,CDC42,GNB1,MAPK1,MAP2K7,RPS6KA1
SMP00321	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	0.00143859247257451	-6.54409009301064	38	13	0.0909090909090909	143	992	2782,5594,5609,6195,673,5567,5170,2002,8874,5290,998,10411,5906	GNB1,MAPK1,MAP2K7,RPS6KA1,BRAF,PRKACB,PDPK1,ELK1,ARHGEF7,PIK3CA,CDC42,RAPGEF3,RAP1A
SMP00623	Heroin Metabolism Pathway	0.0105181397793086	-4.55465391437024	4	3	0.020979020979021	143	992	8824,4988,590	CES2,OPRM1,BCHE
SMP00407	Heroin Action Pathway	0.0160663716678403	-4.13102690768506	29	9	0.0629370629370629	143	992	590,6530,8824,486,6324,4988,6532,148,23439	BCHE,SLC6A2,CES2,FXYD2,SCN1B,OPRM1,SLC6A4,ADRA1A,ATP1B4
SMP00358	Fc Epsilon Receptor I Signaling in Mast Cells	0.030630985840315	-3.485743173206	32	9	0.0629370629370629	143	992	5594,5609,5163,5606,6654,1432,3635,5578,5290	MAPK1,MAP2K7,PDK1,MAP2K3,SOS1,MAPK14,INPP5D,PRKCA,PIK3CA
SMP00398	Lidocaine (Local Anaesthetic) Action Pathway	0.0373486595998458	-3.28745825560161	28	8	0.0559440559440559	143	992	6530,1576,486,6324,6532,4988,148,23439	SLC6A2,CYP3A4,FXYD2,SCN1B,SLC6A4,OPRM1,ADRA1A,ATP1B4
SMP00198	Malonic Aciduria	0.0390523719420324	-3.24285166338791	14	5	0.034965034965035	143	992	5096,84532,18,23417,5095	PCCB,ACSS1,ABAT,MLYCD,PCCA
SMP00016	Propanoate Metabolism	0.0390523719420324	-3.24285166338791	14	5	0.034965034965035	143	992	84532,5096,5095,18,23417	ACSS1,PCCB,PCCA,ABAT,MLYCD
SMP00201	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	0.0390523719420324	-3.24285166338791	14	5	0.034965034965035	143	992	5095,23417,18,84532,5096	PCCA,MLYCD,ABAT,ACSS1,PCCB
SMP00502	Malonyl-coa decarboxylase deficiency	0.0390523719420324	-3.24285166338791	14	5	0.034965034965035	143	992	5096,84532,5095,23417,18	PCCB,ACSS1,PCCA,MLYCD,ABAT
SMP00636	Venlafaxine Metabolism Pathway	0.0421247031753123	-3.16712093661782	6	3	0.020979020979021	143	992	1576,6532,6530	CYP3A4,SLC6A4,SLC6A2
SMP00625	Imipramine Metabolism Pathway	0.0421247031753123	-3.16712093661782	6	3	0.020979020979021	143	992	1576,6530,6532	CYP3A4,SLC6A2,SLC6A4
SMP00405	Codeine Action Pathway	0.0454561978596216	-3.09100610110739	29	8	0.0559440559440559	143	992	4988,6532,23439,148,1576,6530,6324,486	OPRM1,SLC6A4,ATP1B4,ADRA1A,CYP3A4,SLC6A2,SCN1B,FXYD2
SMP00422	Imipramine Action Pathway	0.0546452004413847	-2.90689389179573	30	8	0.0559440559440559	143	992	6530,1576,6324,486,6532,4988,23439,148	SLC6A2,CYP3A4,SCN1B,FXYD2,SLC6A4,OPRM1,ATP1B4,ADRA1A
SMP00626	Desipramine Metabolism Pathway	0.0560832438179307	-2.88091819524085	3	2	0.013986013986014	143	992	6532,6530	SLC6A4,SLC6A2
SMP00367	Carvedilol Action Pathway	0.0609750710340119	-2.79729016991139	58	13	0.0909090909090909	143	992	4638,5573,801,7169,148,23439,6645,486,8912,7135,6833,6331,8913	MYLK,PRKAR1A,CALM1,TPM2,ADRA1A,ATP1B4,SNTB2,FXYD2,CACNA1H,TNNI1,ABCC8,SCN5A,CACNA1G
SMP00368	Labetalol Action Pathway	0.0609750710340119	-2.79729016991139	58	13	0.0909090909090909	143	992	801,7169,148,23439,4638,5573,486,8912,7135,6331,6833,8913,6645	CALM1,TPM2,ADRA1A,ATP1B4,MYLK,PRKAR1A,FXYD2,CACNA1H,TNNI1,SCN5A,ABCC8,CACNA1G,SNTB2
SMP00426	Fluoxetine Action Pathway	0.0649488772943128	-2.7341548217068	31	8	0.0559440559440559	143	992	1576,6530,486,6324,4988,6532,148,23439	CYP3A4,SLC6A2,FXYD2,SCN1B,OPRM1,SLC6A4,ADRA1A,ATP1B4
SMP00410	Hydromorphone Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	23439,148,6324,486,4988,6532,6530	ATP1B4,ADRA1A,SCN1B,FXYD2,OPRM1,SLC6A4,SLC6A2
SMP00689	Dihydromorphine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6324,486,23439,148,6530,6532,4988	SCN1B,FXYD2,ATP1B4,ADRA1A,SLC6A2,SLC6A4,OPRM1
SMP00394	Chloroprocaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6324,486,23439,148,6530,6532,4988	SCN1B,FXYD2,ATP1B4,ADRA1A,SLC6A2,SLC6A4,OPRM1
SMP00411	Hydrocodone Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6532,6530,4988,6324,486,23439,148	SLC6A4,SLC6A2,OPRM1,SCN1B,FXYD2,ATP1B4,ADRA1A
SMP00679	3-Methylthiofentanyl Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	486,6324,148,23439,6530,6532,4988	FXYD2,SCN1B,ADRA1A,ATP1B4,SLC6A2,SLC6A4,OPRM1
SMP00392	Benzocaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6532,6530,148,23439,486,6324	OPRM1,SLC6A4,SLC6A2,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00399	Mepivacaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	23439,148,6324,486,4988,6530,6532	ATP1B4,ADRA1A,SCN1B,FXYD2,OPRM1,SLC6A2,SLC6A4
SMP00688	Naloxone Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6532,6530,23439,148,6324,486	OPRM1,SLC6A4,SLC6A2,ATP1B4,ADRA1A,SCN1B,FXYD2
SMP00416	Remifentanil Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	23439,148,6324,486,4988,6532,6530	ATP1B4,ADRA1A,SCN1B,FXYD2,OPRM1,SLC6A4,SLC6A2
SMP00412	Oxymorphone Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	23439,148,6324,486,4988,6530,6532	ATP1B4,ADRA1A,SCN1B,FXYD2,OPRM1,SLC6A2,SLC6A4
SMP00415	Fentanyl Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6530,6532,4988,486,6324,148,23439	SLC6A2,SLC6A4,OPRM1,FXYD2,SCN1B,ADRA1A,ATP1B4
SMP00417	Sufentanil Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	486,6324,148,23439,6530,6532,4988	FXYD2,SCN1B,ADRA1A,ATP1B4,SLC6A2,SLC6A4,OPRM1
SMP00672	Propoxyphene Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6532,6530,4988,6324,486,23439,148	SLC6A4,SLC6A2,OPRM1,SCN1B,FXYD2,ATP1B4,ADRA1A
SMP00685	Alvimopan Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6530,6532,23439,148,6324,486	OPRM1,SLC6A2,SLC6A4,ATP1B4,ADRA1A,SCN1B,FXYD2
SMP00403	Proparacaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	23439,148,6324,486,4988,6532,6530	ATP1B4,ADRA1A,SCN1B,FXYD2,OPRM1,SLC6A4,SLC6A2
SMP00401	Prilocaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6532,6530,148,23439,486,6324	OPRM1,SLC6A4,SLC6A2,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00683	Levallorphan Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	148,23439,486,6324,4988,6532,6530	ADRA1A,ATP1B4,FXYD2,SCN1B,OPRM1,SLC6A4,SLC6A2
SMP00681	Ethylmorphine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	486,6324,148,23439,6530,6532,4988	FXYD2,SCN1B,ADRA1A,ATP1B4,SLC6A2,SLC6A4,OPRM1
SMP00684	Buprenorphine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6324,486,23439,148,6532,6530,4988	SCN1B,FXYD2,ATP1B4,ADRA1A,SLC6A4,SLC6A2,OPRM1
SMP00690	Ketobemidone  Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6532,6530,148,23439,486,6324	OPRM1,SLC6A4,SLC6A2,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00673	Levorphanol Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	23439,148,6324,486,4988,6530,6532	ATP1B4,ADRA1A,SCN1B,FXYD2,OPRM1,SLC6A2,SLC6A4
SMP00404	Ropivacaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6532,6530,4988,486,6324,148,23439	SLC6A4,SLC6A2,OPRM1,FXYD2,SCN1B,ADRA1A,ATP1B4
SMP00425	Escitalopram Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	486,6324,148,23439,6532,6530,4988	FXYD2,SCN1B,ADRA1A,ATP1B4,SLC6A4,SLC6A2,OPRM1
SMP00395	Cocaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	486,6324,148,23439,6530,6532,4988	FXYD2,SCN1B,ADRA1A,ATP1B4,SLC6A2,SLC6A4,OPRM1
SMP00676	Dezocine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	23439,148,6324,486,4988,6532,6530	ATP1B4,ADRA1A,SCN1B,FXYD2,OPRM1,SLC6A4,SLC6A2
SMP00674	Anileridine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6324,486,23439,148,6532,6530,4988	SCN1B,FXYD2,ATP1B4,ADRA1A,SLC6A4,SLC6A2,OPRM1
SMP00675	Diphenoxylate Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6532,6530,23439,148,6324,486	OPRM1,SLC6A4,SLC6A2,ATP1B4,ADRA1A,SCN1B,FXYD2
SMP00677	Levomethadyl Acetate Action Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	486,6324,148,23439,6532,6530,4988	FXYD2,SCN1B,ADRA1A,ATP1B4,SLC6A4,SLC6A2,OPRM1
SMP00409	Oxycodone Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6530,6532,4988,6324,486,23439,148	SLC6A2,SLC6A4,OPRM1,SCN1B,FXYD2,ATP1B4,ADRA1A
SMP00413	Alfentanil Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	23439,148,6324,486,4988,6530,6532	ATP1B4,ADRA1A,SCN1B,FXYD2,OPRM1,SLC6A2,SLC6A4
SMP00397	Levobupivacaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6532,6530,148,23439,486,6324	OPRM1,SLC6A4,SLC6A2,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00680	Dimethylthiambutene Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6532,6530,148,23439,486,6324	OPRM1,SLC6A4,SLC6A2,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00393	Bupivacaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6324,486,23439,148,6530,6532,4988	SCN1B,FXYD2,ATP1B4,ADRA1A,SLC6A2,SLC6A4,OPRM1
SMP00678	Methadyl Acetate Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6530,6532,148,23439,486,6324	OPRM1,SLC6A2,SLC6A4,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00686	Pentazocine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6532,6530,148,23439,486,6324	OPRM1,SLC6A4,SLC6A2,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00400	Oxybuprocaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6532,6530,148,23439,486,6324	OPRM1,SLC6A4,SLC6A2,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00396	Dibucaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6530,6532,148,23439,486,6324	OPRM1,SLC6A2,SLC6A4,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00671	Tramadol Action Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6530,6532,148,23439,486,6324	OPRM1,SLC6A2,SLC6A4,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00414	Carfentanil Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	4988,6530,6532,23439,148,6324,486	OPRM1,SLC6A2,SLC6A4,ATP1B4,ADRA1A,SCN1B,FXYD2
SMP00687	Naltrexone Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6532,6530,4988,486,6324,148,23439	SLC6A4,SLC6A2,OPRM1,FXYD2,SCN1B,ADRA1A,ATP1B4
SMP00402	Procaine Action Pathway	0.0674422152160371	-2.69648411861511	26	7	0.048951048951049	143	992	6532,6530,4988,6324,486,23439,148	SLC6A4,SLC6A2,OPRM1,SCN1B,FXYD2,ATP1B4,ADRA1A
SMP00328	Lidocaine (Antiarrhythmic) Action Pathway	0.0686694831319725	-2.67845038321678	59	13	0.0909090909090909	143	992	1576,6645,486,8912,6331,6833,7135,8913,4638,5573,801,7169,23439	CYP3A4,SNTB2,FXYD2,CACNA1H,SCN5A,ABCC8,TNNI1,CACNA1G,MYLK,PRKAR1A,CALM1,TPM2,ATP1B4
SMP00408	Methadone Action Pathway	0.0763881744457901	-2.57192737953102	32	8	0.0559440559440559	143	992	6324,486,1576,6530,23439,148,4988,6532	SCN1B,FXYD2,CYP3A4,SLC6A2,ATP1B4,ADRA1A,OPRM1,SLC6A4
SMP00423	Desipramine Action Pathway	0.0804497637309275	-2.52012234239172	27	7	0.048951048951049	143	992	6530,6532,4988,6324,486,23439,148	SLC6A2,SLC6A4,OPRM1,SCN1B,FXYD2,ATP1B4,ADRA1A
SMP00691	Nalbuphine Action Pathway	0.0804497637309275	-2.52012234239172	27	7	0.048951048951049	143	992	148,23439,486,6324,4988,6530,6532	ADRA1A,ATP1B4,FXYD2,SCN1B,OPRM1,SLC6A2,SLC6A4
SMP00354	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	0.0948170196747411	-2.3558063534012	8	3	0.020979020979021	143	992	2782,5567,4638	GNB1,PRKACB,MYLK
SMP00602	Teniposide Metabolism Pathway	0.101648347857909	-2.28623599228228	4	2	0.013986013986014	143	992	1576,4353	CYP3A4,MPO
SMP00443	Teniposide Action Pathway	0.101648347857909	-2.28623599228228	4	2	0.013986013986014	143	992	1576,4353	CYP3A4,MPO
SMP00621	Codeine Metabolism Pathway	0.101648347857909	-2.28623599228228	4	2	0.013986013986014	143	992	1576,4988	CYP3A4,OPRM1
SMP00129	Malate-Aspartate Shuttle	0.101648347857909	-2.28623599228228	4	2	0.013986013986014	143	992	8402,8604	SLC25A11,SLC25A12
SMP00620	Lidocaine (Local Anaesthetic) Metabolism Pathway	0.101648347857909	-2.28623599228228	4	2	0.013986013986014	143	992	6324,1576	SCN1B,CYP3A4
SMP00618	Fosphenytoin (Antiarrhythmic) Metabolism Pathway	0.101648347857909	-2.28623599228228	4	2	0.013986013986014	143	992	6645,6331	SNTB2,SCN5A
SMP00307	Propranolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	801,23439,7169,4638,5573,8912,486,8913,7135,6331,6833,6645	CALM1,ATP1B4,TPM2,MYLK,PRKAR1A,CACNA1H,FXYD2,CACNA1G,TNNI1,SCN5A,ABCC8,SNTB2
SMP00329	Mexiletine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	801,7169,23439,4638,5573,486,8912,6331,7135,6833,8913,6645	CALM1,TPM2,ATP1B4,MYLK,PRKAR1A,FXYD2,CACNA1H,SCN5A,TNNI1,ABCC8,CACNA1G,SNTB2
SMP00323	Quinidine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	5573,4638,7169,23439,801,6645,7135,6833,6331,8913,486,8912	PRKAR1A,MYLK,TPM2,ATP1B4,CALM1,SNTB2,TNNI1,ABCC8,SCN5A,CACNA1G,FXYD2,CACNA1H
SMP00296	Acebutolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,486,8912,6833,7135,6331,8913,4638,5573,801,7169,23439	SNTB2,FXYD2,CACNA1H,ABCC8,TNNI1,SCN5A,CACNA1G,MYLK,PRKAR1A,CALM1,TPM2,ATP1B4
SMP00665	Amiodarone Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	486,8912,6331,6833,7135,8913,6645,801,7169,23439,4638,5573	FXYD2,CACNA1H,SCN5A,ABCC8,TNNI1,CACNA1G,SNTB2,CALM1,TPM2,ATP1B4,MYLK,PRKAR1A
SMP00662	Dobutamine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	486,8912,7135,6331,6833,8913,6645,801,7169,23439,4638,5573	FXYD2,CACNA1H,TNNI1,SCN5A,ABCC8,CACNA1G,SNTB2,CALM1,TPM2,ATP1B4,MYLK,PRKAR1A
SMP00658	Carteolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	486,8912,7135,6833,6331,8913,6645,801,7169,23439,4638,5573	FXYD2,CACNA1H,TNNI1,ABCC8,SCN5A,CACNA1G,SNTB2,CALM1,TPM2,ATP1B4,MYLK,PRKAR1A
SMP00661	Epinephrine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,6833,6331,7135,8913,486,8912,5573,4638,7169,23439,801	SNTB2,ABCC8,SCN5A,TNNI1,CACNA1G,FXYD2,CACNA1H,PRKAR1A,MYLK,TPM2,ATP1B4,CALM1
SMP00325	Disopyramide Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	486,8912,7135,6833,6331,8913,6645,801,7169,23439,4638,5573	FXYD2,CACNA1H,TNNI1,ABCC8,SCN5A,CACNA1G,SNTB2,CALM1,TPM2,ATP1B4,MYLK,PRKAR1A
SMP00326	Fosphenytoin (Antiarrhythmic) Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	801,23439,7169,4638,5573,8912,486,8913,6331,7135,6833,6645	CALM1,ATP1B4,TPM2,MYLK,PRKAR1A,CACNA1H,FXYD2,CACNA1G,SCN5A,TNNI1,ABCC8,SNTB2
SMP00379	Nifedipine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	801,23439,7169,4638,5573,8912,486,8913,7135,6833,6331,6645	CALM1,ATP1B4,TPM2,MYLK,PRKAR1A,CACNA1H,FXYD2,CACNA1G,TNNI1,ABCC8,SCN5A,SNTB2
SMP00382	Nitrendipine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,6833,6331,7135,8913,486,8912,5573,4638,7169,23439,801	SNTB2,ABCC8,SCN5A,TNNI1,CACNA1G,FXYD2,CACNA1H,PRKAR1A,MYLK,TPM2,ATP1B4,CALM1
SMP00378	Isradipine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	4638,5573,801,7169,23439,6645,486,8912,6833,6331,7135,8913	MYLK,PRKAR1A,CALM1,TPM2,ATP1B4,SNTB2,FXYD2,CACNA1H,ABCC8,SCN5A,TNNI1,CACNA1G
SMP00381	Nisoldipine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	486,8912,6331,7135,6833,8913,6645,801,7169,23439,4638,5573	FXYD2,CACNA1H,SCN5A,TNNI1,ABCC8,CACNA1G,SNTB2,CALM1,TPM2,ATP1B4,MYLK,PRKAR1A
SMP00299	Betaxolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,486,8912,7135,6331,6833,8913,4638,5573,801,7169,23439	SNTB2,FXYD2,CACNA1H,TNNI1,SCN5A,ABCC8,CACNA1G,MYLK,PRKAR1A,CALM1,TPM2,ATP1B4
SMP00298	Atenolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,486,8912,7135,6833,6331,8913,4638,5573,801,7169,23439	SNTB2,FXYD2,CACNA1H,TNNI1,ABCC8,SCN5A,CACNA1G,MYLK,PRKAR1A,CALM1,TPM2,ATP1B4
SMP00302	Metoprolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	486,8912,7135,6331,6833,8913,6645,801,7169,23439,4638,5573	FXYD2,CACNA1H,TNNI1,SCN5A,ABCC8,CACNA1G,SNTB2,CALM1,TPM2,ATP1B4,MYLK,PRKAR1A
SMP00306	Pindolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	5573,4638,7169,23439,801,6645,6833,7135,6331,8913,486,8912	PRKAR1A,MYLK,TPM2,ATP1B4,CALM1,SNTB2,ABCC8,TNNI1,SCN5A,CACNA1G,FXYD2,CACNA1H
SMP00669	Practolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,7135,6833,6331,8913,486,8912,5573,4638,7169,23439,801	SNTB2,TNNI1,ABCC8,SCN5A,CACNA1G,FXYD2,CACNA1H,PRKAR1A,MYLK,TPM2,ATP1B4,CALM1
SMP00324	Procainamide (Antiarrhythmic) Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	7169,23439,801,5573,4638,6331,7135,6833,8913,486,8912,6645	TPM2,ATP1B4,CALM1,PRKAR1A,MYLK,SCN5A,TNNI1,ABCC8,CACNA1G,FXYD2,CACNA1H,SNTB2
SMP00667	Metipranolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	8912,486,8913,7135,6833,6331,6645,801,23439,7169,4638,5573	CACNA1H,FXYD2,CACNA1G,TNNI1,ABCC8,SCN5A,SNTB2,CALM1,ATP1B4,TPM2,MYLK,PRKAR1A
SMP00380	Nimodipine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	4638,5573,801,23439,7169,6645,8912,486,8913,6833,6331,7135	MYLK,PRKAR1A,CALM1,ATP1B4,TPM2,SNTB2,CACNA1H,FXYD2,CACNA1G,ABCC8,SCN5A,TNNI1
SMP00301	Esmolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	4638,5573,801,7169,23439,6645,486,8912,6331,7135,6833,8913	MYLK,PRKAR1A,CALM1,TPM2,ATP1B4,SNTB2,FXYD2,CACNA1H,SCN5A,TNNI1,ABCC8,CACNA1G
SMP00663	Isoprenaline Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6833,6331,7135,8913,486,8912,6645,7169,23439,801,5573,4638	ABCC8,SCN5A,TNNI1,CACNA1G,FXYD2,CACNA1H,SNTB2,TPM2,ATP1B4,CALM1,PRKAR1A,MYLK
SMP00664	Arbutamine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	8913,7135,6331,6833,8912,486,6645,23439,7169,801,5573,4638	CACNA1G,TNNI1,SCN5A,ABCC8,CACNA1H,FXYD2,SNTB2,ATP1B4,TPM2,CALM1,PRKAR1A,MYLK
SMP00377	Felodipine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	8912,486,8913,6331,7135,6833,6645,801,23439,7169,4638,5573	CACNA1H,FXYD2,CACNA1G,SCN5A,TNNI1,ABCC8,SNTB2,CALM1,ATP1B4,TPM2,MYLK,PRKAR1A
SMP00297	Alprenolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	8913,7135,6331,6833,8912,486,6645,23439,7169,801,5573,4638	CACNA1G,TNNI1,SCN5A,ABCC8,CACNA1H,FXYD2,SNTB2,ATP1B4,TPM2,CALM1,PRKAR1A,MYLK
SMP00666	Levobunolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	7169,23439,801,5573,4638,7135,6331,6833,8913,486,8912,6645	TPM2,ATP1B4,CALM1,PRKAR1A,MYLK,TNNI1,SCN5A,ABCC8,CACNA1G,FXYD2,CACNA1H,SNTB2
SMP00331	Flecainide Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,6833,6331,7135,8913,486,8912,5573,4638,7169,23439,801	SNTB2,ABCC8,SCN5A,TNNI1,CACNA1G,FXYD2,CACNA1H,PRKAR1A,MYLK,TPM2,ATP1B4,CALM1
SMP00303	Nadolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	4638,5573,801,7169,23439,6645,486,8912,7135,6331,6833,8913	MYLK,PRKAR1A,CALM1,TPM2,ATP1B4,SNTB2,FXYD2,CACNA1H,TNNI1,SCN5A,ABCC8,CACNA1G
SMP00588	Muscle/Heart Contraction	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	5573,4638,23439,7169,801,6645,8913,7135,6833,6331,8912,486	PRKAR1A,MYLK,ATP1B4,TPM2,CALM1,SNTB2,CACNA1G,TNNI1,ABCC8,SCN5A,CACNA1H,FXYD2
SMP00300	Bisoprolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	4638,5573,801,23439,7169,6645,8912,486,8913,6833,6331,7135	MYLK,PRKAR1A,CALM1,ATP1B4,TPM2,SNTB2,CACNA1H,FXYD2,CACNA1G,ABCC8,SCN5A,TNNI1
SMP00304	Oxprenolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	5573,4638,7169,23439,801,6645,7135,6833,6331,8913,486,8912	PRKAR1A,MYLK,TPM2,ATP1B4,CALM1,SNTB2,TNNI1,ABCC8,SCN5A,CACNA1G,FXYD2,CACNA1H
SMP00375	Verapamil Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,8912,486,8913,7135,6331,6833,4638,5573,801,23439,7169	SNTB2,CACNA1H,FXYD2,CACNA1G,TNNI1,SCN5A,ABCC8,MYLK,PRKAR1A,CALM1,ATP1B4,TPM2
SMP00330	Tocainide Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,8913,7135,6833,6331,8912,486,5573,4638,23439,7169,801	SNTB2,CACNA1G,TNNI1,ABCC8,SCN5A,CACNA1H,FXYD2,PRKAR1A,MYLK,ATP1B4,TPM2,CALM1
SMP00305	Penbutolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	5573,4638,23439,7169,801,6645,8913,7135,6833,6331,8912,486	PRKAR1A,MYLK,ATP1B4,TPM2,CALM1,SNTB2,CACNA1G,TNNI1,ABCC8,SCN5A,CACNA1H,FXYD2
SMP00660	Sotalol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	8912,486,8913,6833,7135,6331,6645,801,23439,7169,4638,5573	CACNA1H,FXYD2,CACNA1G,ABCC8,TNNI1,SCN5A,SNTB2,CALM1,ATP1B4,TPM2,MYLK,PRKAR1A
SMP00657	Bopindolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	801,23439,7169,4638,5573,8912,486,8913,6331,7135,6833,6645	CALM1,ATP1B4,TPM2,MYLK,PRKAR1A,CACNA1H,FXYD2,CACNA1G,SCN5A,TNNI1,ABCC8,SNTB2
SMP00366	Nebivolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	4638,5573,801,23439,7169,6645,8912,486,8913,6331,7135,6833	MYLK,PRKAR1A,CALM1,ATP1B4,TPM2,SNTB2,CACNA1H,FXYD2,CACNA1G,SCN5A,TNNI1,ABCC8
SMP00359	Diltiazem Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	6645,8913,6331,6833,7135,8912,486,5573,4638,23439,7169,801	SNTB2,CACNA1G,SCN5A,ABCC8,TNNI1,CACNA1H,FXYD2,PRKAR1A,MYLK,ATP1B4,TPM2,CALM1
SMP00670	Bupranolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	801,23439,7169,4638,5573,8912,486,8913,6331,6833,7135,6645	CALM1,ATP1B4,TPM2,MYLK,PRKAR1A,CACNA1H,FXYD2,CACNA1G,SCN5A,ABCC8,TNNI1,SNTB2
SMP00668	Bevantolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	486,8912,7135,6833,6331,8913,6645,801,7169,23439,4638,5573	FXYD2,CACNA1H,TNNI1,ABCC8,SCN5A,CACNA1G,SNTB2,CALM1,TPM2,ATP1B4,MYLK,PRKAR1A
SMP00376	Amlodipine Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	23439,7169,801,5573,4638,8913,7135,6331,6833,8912,486,6645	ATP1B4,TPM2,CALM1,PRKAR1A,MYLK,CACNA1G,TNNI1,SCN5A,ABCC8,CACNA1H,FXYD2,SNTB2
SMP00659	Timolol Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	801,7169,23439,4638,5573,486,8912,7135,6833,6331,8913,6645	CALM1,TPM2,ATP1B4,MYLK,PRKAR1A,FXYD2,CACNA1H,TNNI1,ABCC8,SCN5A,CACNA1G,SNTB2
SMP00332	Ibutilide Action Pathway	0.104484247314203	-2.25871896234496	57	12	0.0839160839160839	143	992	23439,7169,801,5573,4638,8913,6833,7135,6331,8912,486,6645	ATP1B4,TPM2,CALM1,PRKAR1A,MYLK,CACNA1G,ABCC8,TNNI1,SCN5A,CACNA1H,FXYD2,SNTB2
SMP00355	Mitochondrial Electron Transport Chain	0.125254380440526	-2.07740856605167	19	5	0.034965034965035	143	992	498,2542,54205,2820,6392	ATP5A1,SLC37A4,CYCS,GPD2,SDHD
SMP00312	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	0.127699066491268	-2.05807882614054	9	3	0.020979020979021	143	992	2099,2782,5567	ESR1,GNB1,PRKACB
SMP00309	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	0.127699066491268	-2.05807882614054	9	3	0.020979020979021	143	992	2782,5567,2099	GNB1,PRKACB,ESR1
SMP00333	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	0.127699066491268	-2.05807882614054	9	3	0.020979020979021	143	992	2099,5567,2782	ESR1,PRKACB,GNB1
SMP00311	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	0.127699066491268	-2.05807882614054	9	3	0.020979020979021	143	992	2782,5567,2099	GNB1,PRKACB,ESR1
SMP00335	Intracellular Signalling Through Histamine H2 Receptor and Histamine	0.127699066491268	-2.05807882614054	9	3	0.020979020979021	143	992	2782,5567,2099	GNB1,PRKACB,ESR1
SMP00631	Prednisone Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00036	D-Arginine and D-Ornithine Metabolism	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1610	DAO
SMP00596	Quinapril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00440	Prednisone Action Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00632	Prednisolone Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	3320	HSP90AA1
SMP00597	Ramipril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00598	Spirapril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00441	Prednisolone Action Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	3320	HSP90AA1
SMP00267	Tirofiban Action Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	3674	ITGA2B
SMP00595	Moexipril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00266	Eptifibatide Action Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	3674	ITGA2B
SMP00593	Enalapril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00732	Temocapril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00599	Trandolapril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00591	Benazepril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00594	Fosinopril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00592	Cilazapril Metabolism Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	1636	ACE
SMP00265	Abciximab Action Pathway	0.144153225806569	-1.93687847702415	1	1	0.00699300699300699	143	992	3674	ITGA2B
SMP00310	Corticotropin Activation of Cortisol Production	0.153731536955919	-1.87254746434582	5	2	0.013986013986014	143	992	2782,5567	GNB1,PRKACB
SMP00338	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	0.16395485623069	-1.80816415593686	10	3	0.020979020979021	143	992	5567,2782,2099	PRKACB,GNB1,ESR1
SMP00431	Nicotine Action Pathway	0.165210952326781	-1.80053212271522	32	7	0.048951048951049	143	992	23439,148,6324,486,4988,6530,6532	ATP1B4,ADRA1A,SCN1B,FXYD2,OPRM1,SLC6A2,SLC6A4
SMP00424	Citalopram Action Pathway	0.165210952326781	-1.80053212271522	32	7	0.048951048951049	143	992	486,6324,148,23439,6530,6532,4988	FXYD2,SCN1B,ADRA1A,ATP1B4,SLC6A2,SLC6A4,OPRM1
SMP00391	Insulin Signalling	0.202813531078954	-1.59546828819426	11	3	0.020979020979021	143	992	5170,6654,5594	PDPK1,SOS1,MAPK1
SMP00009	Ammonia Recycling	0.202813531078954	-1.59546828819426	11	3	0.020979020979021	143	992	80150,3034,275	ASRGL1,HAL,AMT
SMP00478	Nucleotide Excision Repair 	0.209534953846434	-1.56286470940116	6	2	0.013986013986014	143	992	5426,25885	POLE,POLR1A
SMP00343	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	0.209534953846434	-1.56286470940116	6	2	0.013986013986014	143	992	2782,5567	GNB1,PRKACB
SMP00308	Dopamine Activation of Neurological Reward System	0.209534953846434	-1.56286470940116	6	2	0.013986013986014	143	992	5567,2782	PRKACB,GNB1
SMP00646	Fluoxetine Metabolism Pathway	0.209534953846434	-1.56286470940116	6	2	0.013986013986014	143	992	6532,1576	SLC6A4,CYP3A4
SMP00322	Vasopressin Regulation of Water Homeostasis	0.266923051946957	-1.32079485707325	7	2	0.013986013986014	143	992	2782,5567	GNB1,PRKACB
SMP00041	Sulfate/Sulfite Metabolism	0.266923051946957	-1.32079485707325	7	2	0.013986013986014	143	992	10380,50515	BPNT1,CHST11
SMP00449	Ethanol Degradation	0.266923051946957	-1.32079485707325	7	2	0.013986013986014	143	992	84532,847	ACSS1,CAT
SMP00532	Sulfite oxidase deficiency	0.266923051946957	-1.32079485707325	7	2	0.013986013986014	143	992	50515,10380	CHST11,BPNT1
SMP02313	sarcosine oncometabolite pathway 	0.285408853870404	-1.25383255174924	13	3	0.020979020979021	143	992	23446,6472,29958	SLC44A1,SHMT2,DMGDH
SMP00327	Phenytoin (Antiarrhythmic) Action Pathway	0.308896764999892	-1.17474815175766	77	13	0.0909090909090909	143	992	6645,1576,8913,6331,6833,7135,8912,486,5573,4638,23439,7169,801	SNTB2,CYP3A4,CACNA1G,SCN5A,ABCC8,TNNI1,CACNA1H,FXYD2,PRKAR1A,MYLK,ATP1B4,TPM2,CALM1
SMP00644	Celecoxib Metabolism Pathway	0.324291729371424	-1.12611176901157	8	2	0.013986013986014	143	992	5742,1576	PTGS1,CYP3A4
SMP00268	Warfarin Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2159,2677,2157	F10,GGCX,F8
SMP00269	Acenocoumarol Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2677,2159,2157	GGCX,F10,F8
SMP00192	Hypoacetylaspartia	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	158,80150,18	ADSL,ASRGL1,ABAT
SMP00288	Aprotinin Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2159,2677,2157	F10,GGCX,F8
SMP00286	Aminocaproic Acid Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2159,2677,2157	F10,GGCX,F8
SMP00277	Bivalirudin Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2159,2677,2157	F10,GGCX,F8
SMP00067	Aspartate Metabolism	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	18,158,80150	ABAT,ADSL,ASRGL1
SMP00270	Dicumarol Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2159,2677	F8,F10,GGCX
SMP00656	Dicoumarol Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2159,2677,2157	F10,GGCX,F8
SMP00271	Phenprocoumon Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2677,2159	F8,GGCX,F10
SMP00281	Anistreplase Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2159,2677,2157	F10,GGCX,F8
SMP00283	Tenecteplase Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2677,2159	F8,GGCX,F10
SMP00276	Argatroban Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2159,2677	F8,F10,GGCX
SMP00655	Phenindione Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2677,2159	F8,GGCX,F10
SMP00284	Urokinase Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2159,2677,2157	F10,GGCX,F8
SMP00586	Coagulation 	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2677,2159,2157	GGCX,F10,F8
SMP00280	Alteplase Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2677,2159	F8,GGCX,F10
SMP00285	Reteplase Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2159,2677	F8,F10,GGCX
SMP00279	Ximelagatran Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2159,2677	F8,F10,GGCX
SMP00278	Lepirudin Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2677,2159,2157	GGCX,F10,F8
SMP00175	Canavan Disease	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	18,158,80150	ABAT,ADSL,ASRGL1
SMP00282	Streptokinase Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2159,2677	F8,F10,GGCX
SMP00287	Tranexamic Acid Action Pathway	0.327824837522997	-1.11527584518592	14	3	0.020979020979021	143	992	2157,2159,2677	F8,F10,GGCX
SMP00406	Morphine Action Pathway	0.351456990069444	-1.04566793632926	40	7	0.048951048951049	143	992	4988,6530,6532,148,23439,486,6324	OPRM1,SLC6A2,SLC6A4,ADRA1A,ATP1B4,FXYD2,SCN1B
SMP00600	Irinotecan Metabolism Pathway	0.358600165440556	-1.02554725645997	21	4	0.027972027972028	143	992	4363,8824,1576,590	ABCC1,CES2,CYP3A4,BCHE
SMP00349	Gaucher Disease	0.358600165440556	-1.02554725645997	21	4	0.027972027972028	143	992	339221,9517,259230,123099	ENPP7,SPTLC2,SGMS1,DEGS2
SMP00526	Krabbe disease	0.358600165440556	-1.02554725645997	21	4	0.027972027972028	143	992	123099,259230,339221,9517	DEGS2,SGMS1,ENPP7,SPTLC2
SMP00525	Fabry disease	0.358600165440556	-1.02554725645997	21	4	0.027972027972028	143	992	259230,123099,339221,9517	SGMS1,DEGS2,ENPP7,SPTLC2
SMP00433	Irinotecan Action Pathway	0.358600165440556	-1.02554725645997	21	4	0.027972027972028	143	992	590,1576,8824,4363	BCHE,CYP3A4,CES2,ABCC1
SMP00348	Globoid Cell Leukodystrophy	0.358600165440556	-1.02554725645997	21	4	0.027972027972028	143	992	339221,9517,123099,259230	ENPP7,SPTLC2,DEGS2,SGMS1
SMP00347	Metachromatic Leukodystrophy (MLD)	0.358600165440556	-1.02554725645997	21	4	0.027972027972028	143	992	339221,9517,123099,259230	ENPP7,SPTLC2,DEGS2,SGMS1
SMP00034	Sphingolipid Metabolism	0.358600165440556	-1.02554725645997	21	4	0.027972027972028	143	992	339221,9517,259230,123099	ENPP7,SPTLC2,SGMS1,DEGS2
SMP00273	Fondaparinux Action Pathway	0.370226364467357	-0.993640664556935	15	3	0.020979020979021	143	992	2157,2159,2677	F8,F10,GGCX
SMP00520	Transaldolase deficiency	0.370226364467357	-0.993640664556935	15	3	0.020979020979021	143	992	7086,2821,51071	TKT,GPI,DERA
SMP00518	Glucose-6-phosphate dehydrogenase deficiency	0.370226364467357	-0.993640664556935	15	3	0.020979020979021	143	992	51071,7086,2821	DERA,TKT,GPI
SMP00274	Heparin Action Pathway	0.370226364467357	-0.993640664556935	15	3	0.020979020979021	143	992	2159,2677,2157	F10,GGCX,F8
SMP00272	Enoxaparin Action Pathway	0.370226364467357	-0.993640664556935	15	3	0.020979020979021	143	992	2159,2677,2157	F10,GGCX,F8
SMP00519	Ribose-5-phosphate isomerase deficiency	0.370226364467357	-0.993640664556935	15	3	0.020979020979021	143	992	51071,2821,7086	DERA,GPI,TKT
SMP00031	Pentose Phosphate Pathway	0.370226364467357	-0.993640664556935	15	3	0.020979020979021	143	992	51071,7086,2821	DERA,TKT,GPI
SMP00275	Ardeparin Action Pathway	0.370226364467357	-0.993640664556935	15	3	0.020979020979021	143	992	2157,2677,2159	F8,GGCX,F10
SMP00464	Vitamin K Metabolism	0.373434567016481	-0.985012478467493	3	1	0.00699300699300699	143	992	2677	GGCX
SMP00124	Glycerol Phosphate Shuttle	0.373434567016481	-0.985012478467493	3	1	0.00699300699300699	143	992	2820	GPD2
SMP00589	Gastric Acid Production	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	759,1811	CA1,SLC26A3
SMP00226	Omeprazole Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	1811,759	SLC26A3,CA1
SMP00225	Esomeprazole Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	759,1811	CA1,SLC26A3
SMP00229	Rabeprazole Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	1811,759	SLC26A3,CA1
SMP00452	Threonine and 2-Oxobutanoate Degradation	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	5095,5096	PCCA,PCCB
SMP00231	Famotidine Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	759,1811	CA1,SLC26A3
SMP00246	Pirenzepine Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	759,1811	CA1,SLC26A3
SMP00736	Betazole Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	1811,759	SLC26A3,CA1
SMP00734	Roxatidine acetate Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	1811,759	SLC26A3,CA1
SMP00232	Cimetidine Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	1811,759	SLC26A3,CA1
SMP00227	Lansoprazole Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	1811,759	SLC26A3,CA1
SMP00233	Nizatidine Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	1811,759	SLC26A3,CA1
SMP00228	Pantoprazole Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	759,1811	CA1,SLC26A3
SMP00735	Metiamide Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	759,1811	CA1,SLC26A3
SMP00230	Ranitidine Action Pathway	0.380461061623125	-0.966371441678783	9	2	0.013986013986014	143	992	1811,759	SLC26A3,CA1
SMP00567	Succinic semialdehyde dehydrogenase deficiency	0.393834500586395	-0.931824507202721	22	4	0.027972027972028	143	992	2729,7915,18,55191	GCLC,ALDH5A1,ABAT,NADSYN1
SMP00339	Hyperinsulinism-Hyperammonemia Syndrome	0.393834500586395	-0.931824507202721	22	4	0.027972027972028	143	992	2729,18,55191,7915	GCLC,ABAT,NADSYN1,ALDH5A1
SMP00072	Glutamate Metabolism	0.393834500586395	-0.931824507202721	22	4	0.027972027972028	143	992	7915,18,55191,2729	ALDH5A1,ABAT,NADSYN1,GCLC
SMP00385	Homocarnosinosis	0.393834500586395	-0.931824507202721	22	4	0.027972027972028	143	992	7915,18,55191,2729	ALDH5A1,ABAT,NADSYN1,GCLC
SMP00243	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	0.393834500586395	-0.931824507202721	22	4	0.027972027972028	143	992	55191,18,7915,2729	NADSYN1,ABAT,ALDH5A1,GCLC
SMP00136	2-Hydroxyglutric Aciduria (D And L Form)	0.393834500586395	-0.931824507202721	22	4	0.027972027972028	143	992	2729,7915,55191,18	GCLC,ALDH5A1,NADSYN1,ABAT
SMP00652	Mycophenolic Acid Metabolism Pathway	0.41214047916553	-0.886391018900905	16	3	0.020979020979021	143	992	54577,1576,8824	UGT1A7,CYP3A4,CES2
SMP00471	Tamoxifen Action Pathway	0.434587612971891	-0.833357713701549	10	2	0.013986013986014	143	992	1576,2099	CYP3A4,ESR1
SMP00606	Tamoxifen Metabolism Pathway	0.434587612971891	-0.833357713701549	10	2	0.013986013986014	143	992	1576,2099	CYP3A4,ESR1
SMP00624	Methadone Metabolism Pathway	0.434587612971891	-0.833357713701549	10	2	0.013986013986014	143	992	4988,1576	OPRM1,CYP3A4
SMP00523	Isobutyryl-coa dehydrogenase deficiency	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	56922,5096,36,18,5095	MCCC1,PCCB,ACADSB,ABAT,PCCA
SMP00521	3-hydroxyisobutyric acid dehydrogenase deficiency	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	5095,18,36,5096,56922	PCCA,ABAT,ACADSB,PCCB,MCCC1
SMP00524	Isovaleric acidemia	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	18,5095,5096,56922,36	ABAT,PCCA,PCCB,MCCC1,ACADSB
SMP00236	Propionic Acidemia	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	5096,56922,36,18,5095	PCCB,MCCC1,ACADSB,ABAT,PCCA
SMP00237	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	18,5095,56922,5096,36	ABAT,PCCA,MCCC1,PCCB,ACADSB
SMP00141	3-Methylglutaconic Aciduria Type IV	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	56922,5096,36,18,5095	MCCC1,PCCB,ACADSB,ABAT,PCCA
SMP02295	The oncogenic action of Fumarate	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	112399,6392,50,22992,48	EGLN3,SDHD,ACO2,KDM2A,ACO1
SMP00137	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	18,5095,5096,56922,36	ABAT,PCCA,PCCB,MCCC1,ACADSB
SMP00140	3-Methylglutaconic Aciduria Type III	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	36,56922,5096,5095,18	ACADSB,MCCC1,PCCB,PCCA,ABAT
SMP00238	Isovaleric Aciduria	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	5095,18,36,5096,56922	PCCA,ABAT,ACADSB,PCCB,MCCC1
SMP00200	Methylmalonic Aciduria	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	18,5095,5096,56922,36	ABAT,PCCA,PCCB,MCCC1,ACADSB
SMP00138	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	18,5095,56922,5096,36	ABAT,PCCA,MCCC1,PCCB,ACADSB
SMP00032	Valine- Leucine and Isoleucine Degradation	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	18,5095,5096,56922,36	ABAT,PCCA,PCCB,MCCC1,ACADSB
SMP00522	3-hydroxyisobutyric aciduria	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	18,5095,56922,5096,36	ABAT,PCCA,MCCC1,PCCB,ACADSB
SMP00384	Methylmalonate Semialdehyde Dehydrogenase Deficiency	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	5095,18,36,56922,5096	PCCA,ABAT,ACADSB,MCCC1,PCCB
SMP02292	The oncogenic action of Succinate	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	48,22992,6392,112399,50	ACO1,KDM2A,SDHD,EGLN3,ACO2
SMP00139	3-Methylglutaconic Aciduria Type I	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	36,56922,5096,5095,18	ACADSB,MCCC1,PCCB,PCCA,ABAT
SMP00173	Beta-Ketothiolase Deficiency	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	18,5095,56922,5096,36	ABAT,PCCA,MCCC1,PCCB,ACADSB
SMP00199	Maple Syrup Urine Disease	0.439586232714056	-0.821921374700006	30	5	0.034965034965035	143	992	5095,18,36,5096,56922	PCCA,ABAT,ACADSB,PCCB,MCCC1
SMP00316	Zellweger Syndrome	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	570,1582,10858	BAAT,CYP8B1,CYP46A1
SMP00217	Sialuria or French Type Sialuria	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	3098,26503,51005	HK1,SLC17A5,AMDHD2
SMP00240	Salla Disease/Infantile Sialic Acid Storage Disease	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	3098,26503,51005	HK1,SLC17A5,AMDHD2
SMP00318	Congenital Bile Acid Synthesis Defect Type III	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	10858,1582,570	CYP46A1,CYP8B1,BAAT
SMP00035	Bile Acid Biosynthesis	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	10858,570,1582	CYP46A1,BAAT,CYP8B1
SMP00045	Amino Sugar Metabolism	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	51005,3098,26503	AMDHD2,HK1,SLC17A5
SMP00314	Congenital Bile Acid Synthesis Defect Type II	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	1582,570,10858	CYP8B1,BAAT,CYP46A1
SMP00317	Familial Hypercholanemia (FHCA)	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	570,1582,10858	BAAT,CYP8B1,CYP46A1
SMP00720	27-Hydroxylase Deficiency	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	570,1582,10858	BAAT,CYP8B1,CYP46A1
SMP00315	Cerebrotendinous Xanthomatosis (CTX)	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	1582,570,10858	CYP8B1,BAAT,CYP46A1
SMP00390	Tay-Sachs Disease	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	51005,3098,26503	AMDHD2,HK1,SLC17A5
SMP00534	G(M2)-Gangliosidosis: Variant B- Tay-sachs disease	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	26503,3098,51005	SLC17A5,HK1,AMDHD2
SMP00216	Sialuria or French Type Sialuria	0.453171158191408	-0.79148539220777	17	3	0.020979020979021	143	992	26503,3098,51005	SLC17A5,HK1,AMDHD2
SMP00162	Losartan Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00157	Trandolapril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00155	Rescinnamine Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00145	Benazepril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00479	Plasmalogen Synthesis	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	8443	GNPAT
SMP00651	Artemether Metabolism Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00148	Enalapril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00639	Clomipramine Metabolism Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00152	Perindopril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00163	Olmesartan Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00147	Cilazapril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00161	Irbesartan Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00076	Thiamine Metabolism	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	79178	THTPA
SMP00150	Lisinopril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00153	Quinapril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00587	Angiotensin Metabolism	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00733	Temocapril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00159	Eprosartan Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00151	Moexipril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00160	Forasartan Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00149	Fosinopril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00156	Spirapril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00164	Telmisartan Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00154	Ramipril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00146	Captopril Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00158	Candesartan Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00633	Felbamate Metabolism Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00065	Ubiquinone Biosynthesis	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	27235	COQ2
SMP00165	Valsartan Action Pathway	0.464029973404847	-0.76780613098696	4	1	0.00699300699300699	143	992	1636	ACE
SMP00015	Glutathione Metabolism	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	2729,290	GCLC,ANPEP
SMP00530	Familial lipoprotein lipase deficiency	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	2820,132158	GPD2,GLYCTK
SMP00187	Glycerol Kinase Deficiency	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	2820,132158	GPD2,GLYCTK
SMP00529	D-glyceric acidura	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	2820,132158	GPD2,GLYCTK
SMP00500	5-oxoprolinase deficiency	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	290,2729	ANPEP,GCLC
SMP00501	Gamma-glutamyl-transpeptidase deficiency	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	2729,290	GCLC,ANPEP
SMP00143	5-Oxoprolinuria	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	2729,290	GCLC,ANPEP
SMP00337	Glutathione Synthetase Deficiency	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	2729,290	GCLC,ANPEP
SMP00439	Vinorelbine Action Pathway	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	4363,1576	ABCC1,CYP3A4
SMP00183	Gamma-Glutamyltransferase Deficiency	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	290,2729	ANPEP,GCLC
SMP00436	Vinblastine Action Pathway	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	1576,4363	CYP3A4,ABCC1
SMP00635	Valproic Acid Metabolism Pathway	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	36,3030	ACADSB,HADHA
SMP00039	Glycerolipid Metabolism	0.486092964504552	-0.721355388385494	11	2	0.013986013986014	143	992	2820,132158	GPD2,GLYCTK
SMP00601	Etoposide Metabolism Pathway	0.492995465115242	-0.70725530353096	18	3	0.020979020979021	143	992	1576,5742,4353	CYP3A4,PTGS1,MPO
SMP00442	Etoposide Action Pathway	0.492995465115242	-0.70725530353096	18	3	0.020979020979021	143	992	1576,5742,4353	CYP3A4,PTGS1,MPO
SMP00242	Dimethylglycine Dehydrogenase Deficiency	0.529698545724093	-0.635447215906271	26	4	0.027972027972028	143	992	6472,29958,275,132158	SHMT2,DMGDH,AMT,GLYCTK
SMP00244	Sarcosinemia	0.529698545724093	-0.635447215906271	26	4	0.027972027972028	143	992	132158,6472,29958,275	GLYCTK,SHMT2,DMGDH,AMT
SMP00179	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	0.529698545724093	-0.635447215906271	26	4	0.027972027972028	143	992	132158,275,29958,6472	GLYCTK,AMT,DMGDH,SHMT2
SMP00223	Non Ketotic Hyperglycinemia	0.529698545724093	-0.635447215906271	26	4	0.027972027972028	143	992	6472,29958,275,132158	SHMT2,DMGDH,AMT,GLYCTK
SMP00004	Glycine and Serine Metabolism	0.529698545724093	-0.635447215906271	26	4	0.027972027972028	143	992	275,29958,6472,132158	AMT,DMGDH,SHMT2,GLYCTK
SMP02291	The oncogenic action of 2-hydroxyglutarate	0.529698545724093	-0.635447215906271	26	4	0.027972027972028	143	992	22992,48,6392,50	KDM2A,ACO1,SDHD,ACO2
SMP00484	Dimethylglycine Dehydrogenase Deficiency	0.529698545724093	-0.635447215906271	26	4	0.027972027972028	143	992	132158,275,6472,29958	GLYCTK,AMT,SHMT2,DMGDH
SMP00485	Hyperglycinemia- non-ketotic	0.529698545724093	-0.635447215906271	26	4	0.027972027972028	143	992	275,6472,29958,132158	AMT,SHMT2,DMGDH,GLYCTK
SMP00721	3-Phosphoglycerate dehydrogenase deficiency	0.529698545724093	-0.635447215906271	26	4	0.027972027972028	143	992	132158,29958,6472,275	GLYCTK,DMGDH,SHMT2,AMT
SMP00053	Folate Metabolism	0.534605650351137	-0.626225906026893	12	2	0.013986013986014	143	992	4524,113235	MTHFR,SLC46A1
SMP00724	Folate malabsorption- hereditary	0.534605650351137	-0.626225906026893	12	2	0.013986013986014	143	992	113235,4524	SLC46A1,MTHFR
SMP00457	Lactose Degradation	0.534605650351137	-0.626225906026893	12	2	0.013986013986014	143	992	486,23439	FXYD2,ATP1B4
SMP00432	Methotrexate Action Pathway	0.534605650351137	-0.626225906026893	12	2	0.013986013986014	143	992	113235,4524	SLC46A1,MTHFR
SMP00543	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.534605650351137	-0.626225906026893	12	2	0.013986013986014	143	992	113235,4524	SLC46A1,MTHFR
SMP00458	Lactose Intolerance	0.534605650351137	-0.626225906026893	12	2	0.013986013986014	143	992	23439,486	ATP1B4,FXYD2
SMP00569	Succinyl CoA: 3-ketoacid CoA transferase deficiency	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	622	BDH1
SMP00468	Degradation of Superoxides	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	847	CAT
SMP00641	Doxepin Metabolism Pathway	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00461	Gliclazide Action Pathway	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	6833	ABCC8
SMP00465	Carnitine Synthesis	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	223	ALDH9A1
SMP00071	Ketone Body Metabolism	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	622	BDH1
SMP00460	Glibenclamide Action Pathway	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	6833	ABCC8
SMP00453	Nateglinide Action Pathway	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	6833	ABCC8
SMP00643	Pancreas Function	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	6833	ABCC8
SMP00454	Repaglinide Action Pathway	0.541604582518583	-0.613219096344195	5	1	0.00699300699300699	143	992	6833	ABCC8
SMP00193	Iminoglycinuria	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	23439,358,486,359,9990	ATP1B4,AQP1,FXYD2,AQP2,SLC12A6
SMP00189	Hartnup Disorder	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	359,486,23439,358,9990	AQP2,FXYD2,ATP1B4,AQP1,SLC12A6
SMP00108	Hydroflumethiazide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,23439,358,486,359	SLC12A6,ATP1B4,AQP1,FXYD2,AQP2
SMP00090	Bendroflumethiazide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,23439,358,359,486	SLC12A6,ATP1B4,AQP1,AQP2,FXYD2
SMP00723	Cystinuria	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	358,23439,486,359,9990	AQP1,ATP1B4,FXYD2,AQP2,SLC12A6
SMP00081	Methyclothiazide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,359,486,358,23439	SLC12A6,AQP2,FXYD2,AQP1,ATP1B4
SMP00197	Lysinuric Protein Intolerance	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,23439,358,486,359	SLC12A6,ATP1B4,AQP1,FXYD2,AQP2
SMP00100	Hydrochlorothiazide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,23439,358,359,486	SLC12A6,ATP1B4,AQP1,AQP2,FXYD2
SMP00133	Amiloride Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	23439,358,486,359,9990	ATP1B4,AQP1,FXYD2,AQP2,SLC12A6
SMP00585	Lysinuric protein intolerance (LPI)	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,23439,358,486,359	SLC12A6,ATP1B4,AQP1,FXYD2,AQP2
SMP00088	Bumetanide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,486,359,23439,358	SLC12A6,FXYD2,AQP2,ATP1B4,AQP1
SMP00103	Cyclothiazide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,359,486,358,23439	SLC12A6,AQP2,FXYD2,AQP1,ATP1B4
SMP00105	Metolazone Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	23439,358,486,359,9990	ATP1B4,AQP1,FXYD2,AQP2,SLC12A6
SMP00078	Chlorothiazide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	486,359,358,23439,9990	FXYD2,AQP2,AQP1,ATP1B4,SLC12A6
SMP00184	Glucose Transporter Defect (SGLT2)	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,486,359,358,23439	SLC12A6,FXYD2,AQP2,AQP1,ATP1B4
SMP00245	Glucose Transporter Defect (SGLT2)	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	23439,358,486,359,9990	ATP1B4,AQP1,FXYD2,AQP2,SLC12A6
SMP00122	Chlorthalidone Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	23439,358,359,486,9990	ATP1B4,AQP1,AQP2,FXYD2,SLC12A6
SMP00121	Trichlormethiazide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,358,23439,486,359	SLC12A6,AQP1,ATP1B4,FXYD2,AQP2
SMP00097	Ethacrynic Acid Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,23439,358,359,486	SLC12A6,ATP1B4,AQP1,AQP2,FXYD2
SMP00132	Triamterene Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	358,23439,359,486,9990	AQP1,ATP1B4,AQP2,FXYD2,SLC12A6
SMP00110	Indapamide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,23439,358,486,359	SLC12A6,ATP1B4,AQP1,FXYD2,AQP2
SMP00135	Eplerenone Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,358,23439,359,486	SLC12A6,AQP1,ATP1B4,AQP2,FXYD2
SMP00118	Torsemide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	358,23439,486,359,9990	AQP1,ATP1B4,FXYD2,AQP2,SLC12A6
SMP00134	Spironolactone Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,486,359,358,23439	SLC12A6,FXYD2,AQP2,AQP1,ATP1B4
SMP00080	Polythiazide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,486,359,358,23439	SLC12A6,FXYD2,AQP2,AQP1,ATP1B4
SMP00091	Quinethazone Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	359,486,358,23439,9990	AQP2,FXYD2,AQP1,ATP1B4,SLC12A6
SMP00483	Kidney Function	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,358,23439,359,486	SLC12A6,AQP1,ATP1B4,AQP2,FXYD2
SMP00115	Furosemide Action Pathway	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	358,23439,359,486,9990	AQP1,ATP1B4,AQP2,FXYD2,SLC12A6
SMP00583	Blue diaper syndrome	0.557200220035983	-0.584830642180686	34	5	0.034965034965035	143	992	9990,358,23439,486,359	SLC12A6,AQP1,ATP1B4,FXYD2,AQP2
SMP00463	Phosphatidylinositol Phosphate Metabolism	0.568064692541505	-0.565519971427014	20	3	0.020979020979021	143	992	2064,5290,3635	ERBB2,PIK3CA,INPP5D
SMP00582	Joubert syndrome	0.568064692541505	-0.565519971427014	20	3	0.020979020979021	143	992	2064,5290,3635	ERBB2,PIK3CA,INPP5D
SMP00467	Trehalose Degradation	0.579914158802817	-0.544875188459167	13	2	0.013986013986014	143	992	486,23439	FXYD2,ATP1B4
SMP00059	Urea Cycle	0.579914158802817	-0.544875188459167	13	2	0.013986013986014	143	992	6509,8604	SLC1A4,SLC25A12
SMP00002	Carbamoyl Phosphate Synthetase Deficiency	0.579914158802817	-0.544875188459167	13	2	0.013986013986014	143	992	8604,6509	SLC25A12,SLC1A4
SMP00205	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	0.579914158802817	-0.544875188459167	13	2	0.013986013986014	143	992	8604,6509	SLC25A12,SLC1A4
SMP00003	Argininosuccinic Aciduria	0.579914158802817	-0.544875188459167	13	2	0.013986013986014	143	992	6509,8604	SLC1A4,SLC25A12
SMP00357	Argininemia	0.579914158802817	-0.544875188459167	13	2	0.013986013986014	143	992	8604,6509	SLC25A12,SLC1A4
SMP00001	Citrullinemia Type I	0.579914158802817	-0.544875188459167	13	2	0.013986013986014	143	992	8604,6509	SLC25A12,SLC1A4
SMP02358	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	0.591984883201056	-0.524274179557509	28	4	0.027972027972028	143	992	22992,48,50,6392	KDM2A,ACO1,ACO2,SDHD
SMP00082	Simvastatin Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	4598,1718,6646	MVK,DHCR24,SOAT1
SMP00107	Zoledronate Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,1718,4598	SOAT1,DHCR24,MVK
SMP00509	Hyper-IgD syndrome	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,4598,1718	SOAT1,MVK,DHCR24
SMP00117	Pamidronate Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	1718,4598,6646	DHCR24,MVK,SOAT1
SMP00511	Wolman disease	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,1718,4598	SOAT1,DHCR24,MVK
SMP00389	Smith-Lemli-Opitz Syndrome (SLOS)	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	4598,1718,6646	MVK,DHCR24,SOAT1
SMP00388	Chondrodysplasia Punctata II- X Linked Dominant (CDPX2)	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,1718,4598	SOAT1,DHCR24,MVK
SMP00131	Atorvastatin Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	4598,1718,6646	MVK,DHCR24,SOAT1
SMP00079	Ibandronate Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	4598,1718,6646	MVK,DHCR24,SOAT1
SMP00510	Mevalonic aciduria	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	1718,4598,6646	DHCR24,MVK,SOAT1
SMP00099	Lovastatin Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,4598,1718	SOAT1,MVK,DHCR24
SMP00387	CHILD Syndrome	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,4598,1718	SOAT1,MVK,DHCR24
SMP00111	Cerivastatin Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	4598,1718,6646	MVK,DHCR24,SOAT1
SMP00011	Inositol Metabolism	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	113026,5290,3705	PLCD3,PIK3CA,ITPK1
SMP00319	Lysosomal Acid Lipase Deficiency (Wolman Disease)	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,4598,1718	SOAT1,MVK,DHCR24
SMP00386	Desmosterolosis	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	1718,4598,6646	DHCR24,MVK,SOAT1
SMP00089	Pravastatin Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	4598,1718,6646	MVK,DHCR24,SOAT1
SMP00092	Rosuvastatin Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,1718,4598	SOAT1,DHCR24,MVK
SMP00119	Fluvastatin Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	1718,4598,6646	DHCR24,MVK,SOAT1
SMP00209	Hypercholesterolemia	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	4598,1718,6646	MVK,DHCR24,SOAT1
SMP00508	Cholesteryl ester storage disease	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,4598,1718	SOAT1,MVK,DHCR24
SMP00023	Steroid Biosynthesis	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	4598,1718,6646	MVK,DHCR24,SOAT1
SMP00112	Risedronate Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	6646,4598,1718	SOAT1,MVK,DHCR24
SMP00095	Alendronate Action Pathway	0.602975447058693	-0.505878801062902	21	3	0.020979020979021	143	992	4598,1718,6646	MVK,DHCR24,SOAT1
SMP00027	Pantothenate and CoA Biosynthesis	0.608018508254222	-0.497549956271693	6	1	0.00699300699300699	143	992	60490	PPCDC
SMP02359	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	0.621272430680746	-0.475985596499559	29	4	0.027972027972028	143	992	6392,50,48,22992	SDHD,ACO2,ACO1,KDM2A
SMP00051	Fatty acid Metabolism	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	36,3030	ACADSB,HADHA
SMP00542	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	3030,36	HADHA,ACADSB
SMP00181	Ethylmalonic Encephalopathy	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	3030,36	HADHA,ACADSB
SMP00540	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	36,3030	ACADSB,HADHA
SMP00541	Carnitine palmitoyl transferase deficiency (II)	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	3030,36	HADHA,ACADSB
SMP00185	Glutaric Aciduria Type I	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	3030,36	HADHA,ACADSB
SMP00538	Carnitine palmitoyl transferase deficiency (I)	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	3030,36	HADHA,ACADSB
SMP00462	Inositol Phosphate Metabolism	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	9807,3705	IP6K1,ITPK1
SMP00539	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	36,3030	ACADSB,HADHA
SMP00191	Histidinemia	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	23438,3034	HARS2,HAL
SMP00044	Histidine Metabolism	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	23438,3034	HARS2,HAL
SMP00545	Trifunctional protein deficiency	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	36,3030	ACADSB,HADHA
SMP00235	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	0.621929045683615	-0.474929267213585	14	2	0.013986013986014	143	992	36,3030	ACADSB,HADHA
SMP00563	Triosephosphate isomerase	0.635997701764591	-0.452560329226231	22	3	0.020979020979021	143	992	2821,8402,2542	GPI,SLC25A11,SLC37A4
SMP00560	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	0.635997701764591	-0.452560329226231	22	3	0.020979020979021	143	992	8402,2542,2821	SLC25A11,SLC37A4,GPI
SMP00573	Glycogenosis- Type IB	0.635997701764591	-0.452560329226231	22	3	0.020979020979021	143	992	2821,8402,2542	GPI,SLC25A11,SLC37A4
SMP00374	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	0.635997701764591	-0.452560329226231	22	3	0.020979020979021	143	992	2821,8402,2542	GPI,SLC25A11,SLC37A4
SMP00128	Gluconeogenesis	0.635997701764591	-0.452560329226231	22	3	0.020979020979021	143	992	8402,2542,2821	SLC25A11,SLC37A4,GPI
SMP00562	Fructose-1-6-diphosphatase deficiency	0.635997701764591	-0.452560329226231	22	3	0.020979020979021	143	992	8402,2542,2821	SLC25A11,SLC37A4,GPI
SMP00574	Glycogenosis- Type IC	0.635997701764591	-0.452560329226231	22	3	0.020979020979021	143	992	2821,8402,2542	GPI,SLC25A11,SLC37A4
SMP00581	Glycogenosis- Type IA. Von gierke disease	0.635997701764591	-0.452560329226231	22	3	0.020979020979021	143	992	8402,2542,2821	SLC25A11,SLC37A4,GPI
SMP00345	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	0.660652535102846	-0.414527242843501	15	2	0.013986013986014	143	992	7390,2235	UROS,FECH
SMP00609	Mercaptopurine Metabolism Pathway	0.660652535102846	-0.414527242843501	15	2	0.013986013986014	143	992	10057,9153	ABCC5,SLC28A2
SMP00024	Porphyrin Metabolism	0.660652535102846	-0.414527242843501	15	2	0.013986013986014	143	992	7390,2235	UROS,FECH
SMP00344	Acute Intermittent Porphyria	0.660652535102846	-0.414527242843501	15	2	0.013986013986014	143	992	7390,2235	UROS,FECH
SMP00346	Porphyria Variegata (PV)	0.660652535102846	-0.414527242843501	15	2	0.013986013986014	143	992	7390,2235	UROS,FECH
SMP00342	Hereditary Coproporphyria (HCP)	0.660652535102846	-0.414527242843501	15	2	0.013986013986014	143	992	7390,2235	UROS,FECH
SMP00434	Paclitaxel Action Pathway	0.664867750974163	-0.40816712881923	7	1	0.00699300699300699	143	992	4363	ABCC1
SMP00637	Tramadol Metabolism Pathway	0.664867750974163	-0.40816712881923	7	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00544	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	0.664867750974163	-0.40816712881923	7	1	0.00699300699300699	143	992	3030	HADHA
SMP00627	Citalopram Metabolism Pathway	0.664867750974163	-0.40816712881923	7	1	0.00699300699300699	143	992	6532	SLC6A4
SMP00054	Fatty Acid Elongation In Mitochondria	0.664867750974163	-0.40816712881923	7	1	0.00699300699300699	143	992	3030	HADHA
SMP00634	Carbamazepine Metabolism Pathway	0.664867750974163	-0.40816712881923	7	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00435	Docetaxel Action Pathway	0.664867750974163	-0.40816712881923	7	1	0.00699300699300699	143	992	4363	ABCC1
SMP00427	Azathioprine Action Pathway	0.694279861909446	-0.364880140526973	47	6	0.041958041958042	143	992	55811,159,2618,158,10057,9153	ADCY10,ADSS,GART,ADSL,ABCC5,SLC28A2
SMP00430	Thioguanine Action Pathway	0.694279861909446	-0.364880140526973	47	6	0.041958041958042	143	992	159,55811,10057,158,9153,2618	ADSS,ADCY10,ABCC5,ADSL,SLC28A2,GART
SMP00428	Mercaptopurine Action Pathway	0.694279861909446	-0.364880140526973	47	6	0.041958041958042	143	992	2618,158,10057,9153,55811,159	GART,ADSL,ABCC5,SLC28A2,ADCY10,ADSS
SMP00481	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	0.713521468347147	-0.337542753734237	8	1	0.00699300699300699	143	992	3030	HADHA
SMP00605	Ifosfamide Metabolism Pathway	0.713521468347147	-0.337542753734237	8	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00466	Transfer of Acetyl Groups into Mitochondria	0.713521468347147	-0.337542753734237	8	1	0.00699300699300699	143	992	8402	SLC25A11
SMP00028	Caffeine Metabolism	0.713521468347147	-0.337542753734237	8	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00127	Glucose-Alanine Cycle	0.713521468347147	-0.337542753734237	8	1	0.00699300699300699	143	992	6509	SLC1A4
SMP00642	Nevirapine Metabolism Pathway	0.713521468347147	-0.337542753734237	8	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00448	Ifosfamide Action Pathway	0.713521468347147	-0.337542753734237	8	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00025	Phospholipid Biosynthesis	0.748641968229139	-0.289494422794783	26	3	0.020979020979021	143	992	5338,1119,2820	PLD2,CHKA,GPD2
SMP00499	Beta-mercaptolactate-cysteine disulfiduria	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	2729	GCLC
SMP00447	Cyclophosphamide Action Pathway	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00722	Cystinosis- ocular nonnephropathic	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	2729	GCLC
SMP00580	GLUT-1 deficiency syndrome	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	6513	SLC2A1
SMP00013	Cysteine Metabolism	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	2729	GCLC
SMP00604	Cyclophosphamide Metabolism Pathway	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00260	Clopidogrel Action Pathway	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00493	Carnosinuria- carnosinemia	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	18	ABAT
SMP00444	Lactose Synthesis	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	6513	SLC2A1
SMP00610	Clopidogrel Metabolism Pathway	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00007	Beta-Alanine Metabolism	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	18	ABAT
SMP00579	Congenital disorder of glycosylation CDG-IId	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	6513	SLC2A1
SMP00351	GABA-Transaminase Deficiency	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	18	ABAT
SMP00716	Thyroid hormone synthesis	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	7038	TG
SMP00492	Ureidopropionase deficiency	0.755154019189129	-0.280833551612065	9	1	0.00699300699300699	143	992	18	ABAT
SMP00725	Fructose intolerance- hereditary	0.757996571293249	-0.277076416709826	18	2	0.013986013986014	143	992	3098,6652	HK1,SORD
SMP00649	Lamivudine Metabolism Pathway	0.757996571293249	-0.277076416709826	18	2	0.013986013986014	143	992	4363,5833	ABCC1,PCYT2
SMP00064	Fructose and Mannose Degradation	0.757996571293249	-0.277076416709826	18	2	0.013986013986014	143	992	6652,3098	SORD,HK1
SMP00561	Fructosuria	0.757996571293249	-0.277076416709826	18	2	0.013986013986014	143	992	6652,3098	SORD,HK1
SMP02298	Glutaminolysis and Cancer	0.76797474420474	-0.263998431525272	35	4	0.027972027972028	143	992	6509,55662,50,6392	SLC1A4,HIF1AN,ACO2,SDHD
SMP00340	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.784659926946003	-0.242504869145583	19	2	0.013986013986014	143	992	4524,1786	MTHFR,DNMT1
SMP00177	Cystathionine Beta-Synthase Deficiency	0.784659926946003	-0.242504869145583	19	2	0.013986013986014	143	992	4524,1786	MTHFR,DNMT1
SMP00341	Hypermethioninemia	0.784659926946003	-0.242504869145583	19	2	0.013986013986014	143	992	1786,4524	DNMT1,MTHFR
SMP00221	Methionine Adenosyltransferase Deficiency	0.784659926946003	-0.242504869145583	19	2	0.013986013986014	143	992	1786,4524	DNMT1,MTHFR
SMP00570	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism- cblG complementation type	0.784659926946003	-0.242504869145583	19	2	0.013986013986014	143	992	4524,1786	MTHFR,DNMT1
SMP00214	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	0.784659926946003	-0.242504869145583	19	2	0.013986013986014	143	992	1786,4524	DNMT1,MTHFR
SMP00222	Glycine N-methyltransferase Deficiency	0.784659926946003	-0.242504869145583	19	2	0.013986013986014	143	992	4524,1786	MTHFR,DNMT1
SMP00033	Methionine Metabolism	0.784659926946003	-0.242504869145583	19	2	0.013986013986014	143	992	4524,1786	MTHFR,DNMT1
SMP00654	Warburg Effect	0.785804323801907	-0.241047469452572	44	5	0.034965034965035	143	992	7086,50,6392,2821,48	TKT,ACO2,SDHD,GPI,ACO1
SMP00438	Vindesine Action Pathway	0.790772508770599	-0.23474495211064	10	1	0.00699300699300699	143	992	4363	ABCC1
SMP00482	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	0.790772508770599	-0.23474495211064	10	1	0.00699300699300699	143	992	3030	HADHA
SMP00437	Vincristine Action Pathway	0.790772508770599	-0.23474495211064	10	1	0.00699300699300699	143	992	4363	ABCC1
SMP00640	Acetaminophen Metabolism Pathway	0.793650567273491	-0.231112006198829	28	3	0.020979020979021	143	992	1576,4363,10057	CYP3A4,ABCC1,ABCC5
SMP00535	Adenine phosphoribosyltransferase deficiency (APRT)	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	55811,159,2618,158	ADCY10,ADSS,GART,ADSL
SMP00365	Gout or Kelley-Seegmiller Syndrome	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	55811,159,2618,158	ADCY10,ADSS,GART,ADSL
SMP00144	Adenosine Deaminase Deficiency	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	158,2618,159,55811	ADSL,GART,ADSS,ADCY10
SMP00203	Molybdenum Cofactor Deficiency	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	159,55811,158,2618	ADSS,ADCY10,ADSL,GART
SMP00537	Myoadenylate deaminase deficiency	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	55811,159,2618,158	ADCY10,ADSS,GART,ADSL
SMP00168	AICA-Ribosiduria	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	159,55811,158,2618	ADSS,ADCY10,ADSL,GART
SMP00220	Xanthine Dehydrogenase Deficiency (Xanthinuria)	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	159,55811,158,2618	ADSS,ADCY10,ADSL,GART
SMP00167	Adenylosuccinate Lyase Deficiency	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	2618,158,55811,159	GART,ADSL,ADCY10,ADSS
SMP00513	Xanthinuria type II	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	55811,159,2618,158	ADCY10,ADSS,GART,ADSL
SMP00536	Mitochondrial DNA depletion syndrome	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	2618,158,55811,159	GART,ADSL,ADCY10,ADSS
SMP00210	Purine Nucleoside Phosphorylase Deficiency	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	158,2618,159,55811	ADSL,GART,ADSS,ADCY10
SMP00364	Lesch-Nyhan Syndrome (LNS)	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	158,2618,159,55811	ADSL,GART,ADSS,ADCY10
SMP00512	Xanthinuria type I	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	55811,159,2618,158	ADCY10,ADSS,GART,ADSL
SMP00050	Purine Metabolism	0.805803576454668	-0.215915267844733	37	4	0.027972027972028	143	992	55811,159,2618,158	ADCY10,ADSS,GART,ADSL
SMP00547	Fumarase deficiency	0.808726064103529	-0.212295029767562	20	2	0.013986013986014	143	992	50,6392	ACO2,SDHD
SMP00549	2-ketoglutarate dehydrogenase complex deficiency	0.808726064103529	-0.212295029767562	20	2	0.013986013986014	143	992	6392,50	SDHD,ACO2
SMP00057	Citric Acid Cycle	0.808726064103529	-0.212295029767562	20	2	0.013986013986014	143	992	6392,50	SDHD,ACO2
SMP00550	Pyruvate dehydrogenase deficiency (E3)	0.808726064103529	-0.212295029767562	20	2	0.013986013986014	143	992	50,6392	ACO2,SDHD
SMP00551	Pyruvate dehydrogenase deficiency (E2)	0.808726064103529	-0.212295029767562	20	2	0.013986013986014	143	992	6392,50	SDHD,ACO2
SMP00548	Mitochondrial complex II deficiency	0.808726064103529	-0.212295029767562	20	2	0.013986013986014	143	992	50,6392	ACO2,SDHD
SMP00546	Congenital lactic acidosis	0.808726064103529	-0.212295029767562	20	2	0.013986013986014	143	992	50,6392	ACO2,SDHD
SMP00008	Phenylalanine and Tyrosine Metabolism	0.821240463199313	-0.196939321793436	11	1	0.00699300699300699	143	992	5053	PAH
SMP00206	Phenylketonuria	0.821240463199313	-0.196939321793436	11	1	0.00699300699300699	143	992	5053	PAH
SMP00370	Tyrosinemia Type 3 (TYRO3)	0.821240463199313	-0.196939321793436	11	1	0.00699300699300699	143	992	5053	PAH
SMP00029	Selenoamino Acid Metabolism	0.821240463199313	-0.196939321793436	11	1	0.00699300699300699	143	992	51540	SCLY
SMP00369	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	0.821240463199313	-0.196939321793436	11	1	0.00699300699300699	143	992	5053	PAH
SMP00554	Glycogenosis- Type IV. Amylopectinosis	0.847298173458882	-0.165702611499525	12	1	0.00699300699300699	143	992	2821	GPI
SMP00494	Tyrosinemia- transient	0.847298173458882	-0.165702611499525	12	1	0.00699300699300699	143	992	26	AOC1
SMP00565	Aromatase deficiency	0.847298173458882	-0.165702611499525	12	1	0.00699300699300699	143	992	412	STS
SMP00356	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	0.847298173458882	-0.165702611499525	12	1	0.00699300699300699	143	992	412	STS
SMP00068	Androgen and Estrogen Metabolism	0.847298173458882	-0.165702611499525	12	1	0.00699300699300699	143	992	412	STS
SMP00553	Glycogenosis- Type III. Cori disease	0.847298173458882	-0.165702611499525	12	1	0.00699300699300699	143	992	2821	GPI
SMP00590	Ibuprofen Metabolism Pathway	0.849822655995483	-0.162727591271443	22	2	0.013986013986014	143	992	5742,1576	PTGS1,CYP3A4
SMP00571	Pyridoxine dependency with seizures	0.869580174682035	-0.139744741638752	13	1	0.00699300699300699	143	992	6542	SLC7A2
SMP00043	Galactose Metabolism	0.869580174682035	-0.139744741638752	13	1	0.00699300699300699	143	992	3098	HK1
SMP00182	Galactosemia	0.869580174682035	-0.139744741638752	13	1	0.00699300699300699	143	992	3098	HK1
SMP00239	Saccharopinuria/Hyperlysinemia II	0.869580174682035	-0.139744741638752	13	1	0.00699300699300699	143	992	6542	SLC7A2
SMP00719	2-aminoadipic 2-oxoadipic aciduria	0.869580174682035	-0.139744741638752	13	1	0.00699300699300699	143	992	6542	SLC7A2
SMP00186	Glutaric Aciduria Type I	0.869580174682035	-0.139744741638752	13	1	0.00699300699300699	143	992	6542	SLC7A2
SMP00037	Lysine Degradation	0.869580174682035	-0.139744741638752	13	1	0.00699300699300699	143	992	6542	SLC7A2
SMP00527	Hyperlysinemia I- Familial	0.869580174682035	-0.139744741638752	13	1	0.00699300699300699	143	992	6542	SLC7A2
SMP00528	Hyperlysinemia II or Saccharopinuria	0.869580174682035	-0.139744741638752	13	1	0.00699300699300699	143	992	6542	SLC7A2
SMP00429	Disulfiram Action Pathway	0.882774377249474	-0.124685629432333	24	2	0.013986013986014	143	992	847,84532	CAT,ACSS1
SMP00648	Sorafenib Metabolism Pathway	0.888630261529603	-0.118074033771425	14	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00048	Nicotinate and Nicotinamide Metabolism	0.888630261529603	-0.118074033771425	14	1	0.00699300699300699	143	992	55191	NADSYN1
SMP00096	Celecoxib Action Pathway	0.890328032309349	-0.116165308534781	34	3	0.020979020979021	143	992	1576,5742,5740	CYP3A4,PTGS1,PTGIS
SMP00531	Glycogenosis- Type VII. Tarui disease	0.904914384848275	-0.0999149421348947	15	1	0.00699300699300699	143	992	2821	GPI
SMP00622	Morphine Metabolism Pathway	0.904914384848275	-0.0999149421348947	15	1	0.00699300699300699	143	992	4988	OPRM1
SMP00040	Glycolysis	0.904914384848275	-0.0999149421348947	15	1	0.00699300699300699	143	992	2821	GPI
SMP00572	Fanconi-bickel syndrome	0.904914384848275	-0.0999149421348947	15	1	0.00699300699300699	143	992	2821	GPI
SMP00552	Glycogen synthetase deficiency	0.918831726680725	-0.084652278200969	16	1	0.00699300699300699	143	992	2821	GPI
SMP00557	Sucrase-isomaltase deficiency	0.918831726680725	-0.084652278200969	16	1	0.00699300699300699	143	992	2821	GPI
SMP00556	Mucopolysaccharidosis VI. Sly syndrome	0.918831726680725	-0.084652278200969	16	1	0.00699300699300699	143	992	2821	GPI
SMP00555	Glycogenosis- Type VI. Hers disease	0.918831726680725	-0.084652278200969	16	1	0.00699300699300699	143	992	2821	GPI
SMP00058	Starch and Sucrose Metabolism	0.918831726680725	-0.084652278200969	16	1	0.00699300699300699	143	992	2821	GPI
SMP00701	Phenylbutazone Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00702	Nepafenac Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00697	Flurbiprofen Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00094	Sulindac Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00289	Diflunisal Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00710	Acetaminophen  Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00704	Tolmetin Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00098	Ketorolac Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00694	Carprofen Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00708	Salicylate-sodium Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00693	Antrafenine Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00116	Valdecoxib Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00353	Leukotriene C4 Synthesis Deficiency	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00692	Antipyrine Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00114	Nabumetone Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00703	Trisalicylate-choline Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00113	Oxaprozin Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00077	Piroxicam Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00087	Rofecoxib Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00085	Ketoprofen Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00075	Arachidonic Acid Metabolism	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00707	Salsalate Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00706	Tenoxicam Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00102	Bromfenac Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00120	Naproxen Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00695	Etoricoxib Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00699	Lumiracoxib Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00696	Fenoprofen Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00084	Etodolac Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00093	Diclofenac Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00106	Meloxicam Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00705	Tiaprofenic Acid Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00109	Mefenamic Acid Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00709	Salicylic Acid Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00083	Acetylsalicylic Acid Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00700	Lornoxicam Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00101	Suprofen Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5742,5740	PTGS1,PTGIS
SMP00698	Magnesium salicylate Action Pathway	0.929634629200543	-0.0729636418565637	28	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00650	Doxorubicin Metabolism Pathway	0.930724209353792	-0.0717922761444736	17	1	0.00699300699300699	143	992	4363	ABCC1
SMP00104	Indomethacin Action Pathway	0.938234205270125	-0.0637556753531755	29	2	0.013986013986014	143	992	5740,5742	PTGIS,PTGS1
SMP00063	Tryptophan Metabolism	0.949563810414425	-0.0517525467599635	19	1	0.00699300699300699	143	992	847	CAT
SMP00360	Hyperprolinemia Type II	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00188	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00506	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00363	Ornithine Aminotransferase Deficiency (OAT Deficiency)	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00504	Creatine deficiency- guanidinoacetate methyltransferase deficiency	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00207	Prolidase Deficiency (PD)	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00505	Hyperornithinemia with gyrate atrophy (HOGA)	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00362	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00020	Arginine and Proline Metabolism	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00507	L-arginine:glycine amidinotransferase deficiency	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00208	Prolinemia Type II	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00361	Hyperprolinemia Type I	0.956976323380113	-0.0439766282948854	20	1	0.00699300699300699	143	992	1610	DAO
SMP00086	Ibuprofen Action Pathway	0.976161459003591	-0.0241272769440052	47	3	0.020979020979021	143	992	5742,5740,1576	PTGS1,PTGIS,CYP3A4
SMP00074	Retinol Metabolism	0.996119833285266	-0.00388771409131368	35	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00336	Vitamin A Deficiency	0.996119833285266	-0.00388771409131368	35	1	0.00699300699300699	143	992	1576	CYP3A4
SMP00613	Omeprazole Metabolism Pathway	0.999999999996642	-3.35765790171472e-12	2	0	0	143	992
SMP00614	Lansoprazole Metabolism Pathway	0.999999999996642	-3.35765790171472e-12	2	0	0	143	992
SMP00455	Homocysteine Degradation	0.999999999996642	-3.35765790171472e-12	2	0	0	143	992
SMP00515	Homocystinuria- cystathionine beta-synthase deficiency	0.999999999996642	-3.35765790171472e-12	2	0	0	143	992
SMP00612	Esomeprazole Metabolism Pathway	0.999999999996642	-3.35765790171472e-12	2	0	0	143	992
SMP00514	Gamma-cystathionase deficiency (CTH)	0.999999999996642	-3.35765790171472e-12	2	0	0	143	992
SMP00616	Rabeprazole Metabolism Pathway	0.999999999996642	-3.35765790171472e-12	2	0	0	143	992
SMP00615	Pantoprazole Metabolism Pathway	0.999999999996642	-3.35765790171472e-12	2	0	0	143	992
SMP00456	Fatty Acid Biosynthesis	0.999999999996642	-3.35765790171472e-12	2	0	0	143	992
SMP00653	Rosiglitazone Metabolism Pathway	1.00000000000011	1.13976970222973e-13	3	0	0	143	992
SMP00066	Biotin Metabolism	1.00000000000011	1.13976970222973e-13	3	0	0	143	992
SMP00619	Felodipine Metabolism Pathway	1.00000000000011	1.13976970222973e-13	3	0	0	143	992
SMP00564	Multiple carboxylase deficiency- neonatal or early onset form	1.00000000000011	1.13976970222973e-13	3	0	0	143	992
SMP00472	Erlotinib Action Pathway	1.00000000000011	1.13976970222973e-13	3	0	0	143	992
SMP00126	Phenylacetate Metabolism	1.00000000000011	1.13976970222973e-13	3	0	0	143	992
SMP00174	Biotinidase Deficiency	1.00000000000011	1.13976970222973e-13	3	0	0	143	992
SMP00420	Bevacizumab Action Pathway	1.00000000000011	1.13976970222973e-13	3	0	0	143	992
SMP00459	Pyruvaldehyde Degradation	1.00000000000011	1.13976970222973e-13	3	0	0	143	992
SMP00611	Ticlopidine Metabolism Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00475	Panitumumab Action Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00261	Ticlopidine Action Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00617	Cimetidine Metabolism Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00476	Trastuzumab Action Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00264	Dipyridamole (Antiplatelet) Action Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00263	Cilostazol Action Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00608	Fluorouracil Metabolism Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00474	Cetuximab Action Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00647	Thioguanine Metabolism Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00421	Vatalanib Action Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00473	Gefitinib Action Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00638	Levomethadyl Acetate Metabolism Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00470	Fluorouracil Action Pathway	1.00000000000058	5.80951953210729e-13	1	0	0	143	992
SMP00450	Phytanic Acid Peroxisomal Oxidation	1.00000000000094	9.40267069933498e-13	4	0	0	143	992
SMP00170	Aromatic L-Aminoacid Decarboxylase Deficiency	1.00000000000094	9.40267069933498e-13	4	0	0	143	992
SMP00012	Catecholamine Biosynthesis	1.00000000000094	9.40267069933498e-13	4	0	0	143	992
SMP00630	Tenofovir Metabolism Pathway	1.00000000000094	9.40267069933498e-13	4	0	0	143	992
SMP00629	Adefovir Dipivoxil Metabolism Pathway	1.00000000000094	9.40267069933498e-13	4	0	0	143	992
SMP00451	Refsum Disease	1.00000000000094	9.40267069933498e-13	4	0	0	143	992
SMP00497	Tyrosine hydroxylase deficiency	1.00000000000094	9.40267069933498e-13	4	0	0	143	992
SMP00352	Primary Hyperoxaluria Type I	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00018	Alpha Linolenic Acid and Linoleic Acid Metabolism	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00052	Beta Oxidation of Very Long Chain Fatty Acids	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00070	Riboflavin Metabolism	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00516	Adrenoleukodystrophy- X-linked	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00021	Taurine and Hypotaurine Metabolism	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00350	Pyruvate Carboxylase Deficiency	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00313	Lactic Acidemia	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00517	Carnitine-acylcarnitine translocase deficiency	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00503	Hypophosphatasia	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00469	Capecitabine Action Pathway	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00607	Capecitabine Metabolism Pathway	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00017	Vitamin B6 Metabolism	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00055	Alanine Metabolism	1.00000000000194	1.93980674757658e-12	5	0	0	143	992
SMP00628	Nicotine Metabolism Pathway	1.0000000000032	3.19608916731688e-12	6	0	0	143	992
SMP00445	Spermidine and Spermine Biosynthesis	1.0000000000032	3.19608916731688e-12	6	0	0	143	992
SMP00682	Leucine Stimulation on Insulin Signaling	1.00000000000491	4.90766541395507e-12	7	0	0	143	992
SMP00488	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00030	Oxidation of Branched Chain Fatty Acids	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00486	Dopa-responsive dystonia	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00123	Betaine Metabolism	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00568	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00491	Sepiapterin reductase deficiency	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00489	Hyperphenylalaninemia due to dhpr-deficiency	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00005	Pterine Biosynthesis	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00480	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00490	Segawa syndrome	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00496	Galactosemia III	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00495	Galactosemia II (GALK)	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00073	Butyrate Metabolism	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00010	Nucleotide Sugars Metabolism	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00487	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	1.00000000000595	5.95014005089991e-12	8	0	0	143	992
SMP00717	Apparent mineralocorticoid excess syndrome	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00718	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00566	17-alpha-hydroxylase deficiency (CYP17)	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00373	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00576	21-hydroxylase deficiency (CYP21)	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00577	Corticosterone methyl oxidase I deficiency (CMO I)	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00371	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00578	Corticosterone methyl oxidase II deficiency - CMO II	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00130	Steroidogenesis	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00372	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00575	11-beta-hydroxylase deficiency (CYP11B1)	1.00000000001087	1.0868478382706e-11	11	0	0	143	992
SMP00603	Gemcitabine Metabolism Pathway	1.00000000001312	1.31221349409944e-11	13	0	0	143	992
SMP00446	Gemcitabine Action Pathway	1.00000000001312	1.31221349409944e-11	13	0	0	143	992
SMP00190	Hawkinsinuria	1.00000000001988	1.98788084879558e-11	17	0	0	143	992
SMP00533	Monoamine oxidase-a deficiency (MAO-A)	1.00000000001988	1.98788084879558e-11	17	0	0	143	992
SMP00006	Tyrosine Metabolism	1.00000000001988	1.98788084879558e-11	17	0	0	143	992
SMP00498	Dopamine beta-hydroxylase deficiency	1.00000000001988	1.98788084879558e-11	17	0	0	143	992
SMP00169	Alkaptonuria	1.00000000001988	1.98788084879558e-11	17	0	0	143	992
SMP00218	Tyrosinemia Type I	1.00000000001988	1.98788084879558e-11	17	0	0	143	992
SMP00212	Pyruvate Dehydrogenase Complex Deficiency	1.00000000002396	2.39622773288124e-11	21	0	0	143	992
SMP00060	Pyruvate Metabolism	1.00000000002396	2.39622773288124e-11	21	0	0	143	992
SMP00558	Primary hyperoxaluria II- PH2	1.00000000002396	2.39622773288124e-11	21	0	0	143	992
SMP00334	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	1.00000000002396	2.39622773288124e-11	21	0	0	143	992
SMP00559	Pyruvate kinase deficiency	1.00000000002396	2.39622773288124e-11	21	0	0	143	992
SMP00196	Leigh Syndrome	1.00000000002396	2.39622773288124e-11	21	0	0	143	992
SMP00219	UMP Synthase Deiciency (Orotic Aciduria)	1.00000000002481	2.48061585717232e-11	23	0	0	143	992
SMP00046	Pyrimidine Metabolism	1.00000000002481	2.48061585717232e-11	23	0	0	143	992
SMP00202	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	1.00000000002481	2.48061585717232e-11	23	0	0	143	992
SMP00178	Dihydropyrimidinase Deficiency	1.00000000002481	2.48061585717232e-11	23	0	0	143	992
SMP00172	Beta Ureidopropionase Deficiency	1.00000000002481	2.48061585717232e-11	23	0	0	143	992
